

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 8.65356184 |
| 2 | regulation of fibrinolysis (GO:0051917) | 8.56700617 |
| 3 | glyoxylate metabolic process (GO:0046487) | 7.47141000 |
| 4 | complement activation, alternative pathway (GO:0006957) | 7.38045999 |
| 5 | regulation of protein activation cascade (GO:2000257) | 7.35882596 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 7.33343223 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.33343223 |
| 8 | drug catabolic process (GO:0042737) | 7.23193755 |
| 9 | exogenous drug catabolic process (GO:0042738) | 7.15946695 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.03069864 |
| 11 | protein carboxylation (GO:0018214) | 7.03069864 |
| 12 | regulation of complement activation (GO:0030449) | 6.91065687 |
| 13 | negative regulation of cholesterol transport (GO:0032375) | 6.87005143 |
| 14 | negative regulation of sterol transport (GO:0032372) | 6.87005143 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.78816779 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 6.78816779 |
| 17 | fibrinolysis (GO:0042730) | 6.76353717 |
| 18 | epoxygenase P450 pathway (GO:0019373) | 6.38104107 |
| 19 | phospholipid efflux (GO:0033700) | 6.21862996 |
| 20 | urea metabolic process (GO:0019627) | 6.21845236 |
| 21 | blood coagulation, intrinsic pathway (GO:0007597) | 6.14060747 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.10357673 |
| 23 | regulation of cholesterol esterification (GO:0010872) | 5.96075226 |
| 24 | omega-hydroxylase P450 pathway (GO:0097267) | 5.87678805 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.64071737 |
| 26 | cellular glucuronidation (GO:0052695) | 5.58920881 |
| 27 | regulation of plasminogen activation (GO:0010755) | 5.58583754 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 5.49571622 |
| 29 | urea cycle (GO:0000050) | 5.47211487 |
| 30 | protein-lipid complex remodeling (GO:0034368) | 5.44296238 |
| 31 | macromolecular complex remodeling (GO:0034367) | 5.44296238 |
| 32 | plasma lipoprotein particle remodeling (GO:0034369) | 5.44296238 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 5.42916990 |
| 34 | glucuronate metabolic process (GO:0019585) | 5.32622384 |
| 35 | uronic acid metabolic process (GO:0006063) | 5.32622384 |
| 36 | cholesterol efflux (GO:0033344) | 5.27574328 |
| 37 | ethanol oxidation (GO:0006069) | 5.24142360 |
| 38 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.22607950 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 5.20572734 |
| 40 | bile acid biosynthetic process (GO:0006699) | 5.18930667 |
| 41 | aromatic amino acid family catabolic process (GO:0009074) | 5.18296240 |
| 42 | negative regulation of hemostasis (GO:1900047) | 5.12803306 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 5.12803306 |
| 44 | drug metabolic process (GO:0017144) | 4.94444973 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.89477283 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.89477283 |
| 47 | oxidative demethylation (GO:0070989) | 4.88189098 |
| 48 | reverse cholesterol transport (GO:0043691) | 4.87002248 |
| 49 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.82936789 |
| 50 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.82936789 |
| 51 | phenylpropanoid metabolic process (GO:0009698) | 4.81612940 |
| 52 | bile acid metabolic process (GO:0008206) | 4.80568373 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.79343801 |
| 54 | protein activation cascade (GO:0072376) | 4.77318589 |
| 55 | plasma lipoprotein particle assembly (GO:0034377) | 4.71584481 |
| 56 | negative regulation of lipase activity (GO:0060192) | 4.69418017 |
| 57 | negative regulation of coagulation (GO:0050819) | 4.67946009 |
| 58 | positive regulation of blood coagulation (GO:0030194) | 4.60402775 |
| 59 | positive regulation of hemostasis (GO:1900048) | 4.60402775 |
| 60 | glycine metabolic process (GO:0006544) | 4.58245117 |
| 61 | negative regulation of wound healing (GO:0061045) | 4.57511895 |
| 62 | acute-phase response (GO:0006953) | 4.39842301 |
| 63 | negative regulation of protein activation cascade (GO:2000258) | 4.32038661 |
| 64 | regulation of humoral immune response (GO:0002920) | 4.30691125 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.29929237 |
| 66 | regulation of lipoprotein particle clearance (GO:0010984) | 4.26958866 |
| 67 | complement activation (GO:0006956) | 4.26282364 |
| 68 | positive regulation of coagulation (GO:0050820) | 4.26066400 |
| 69 | ethanol metabolic process (GO:0006067) | 4.24151971 |
| 70 | complement activation, classical pathway (GO:0006958) | 4.24068177 |
| 71 | plasma lipoprotein particle organization (GO:0071827) | 4.23501415 |
| 72 | protein-lipid complex assembly (GO:0065005) | 4.23104669 |
| 73 | intestinal cholesterol absorption (GO:0030299) | 4.19337850 |
| 74 | tyrosine metabolic process (GO:0006570) | 4.05450620 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 4.04586569 |
| 76 | protein-lipid complex subunit organization (GO:0071825) | 3.99972006 |
| 77 | alkaloid metabolic process (GO:0009820) | 3.90465785 |
| 78 | amino-acid betaine metabolic process (GO:0006577) | 3.89558659 |
| 79 | imidazole-containing compound metabolic process (GO:0052803) | 3.88372207 |
| 80 | regulation of apoptotic cell clearance (GO:2000425) | 3.83872929 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 3.76828108 |
| 82 | S-adenosylmethionine metabolic process (GO:0046500) | 3.74816718 |
| 83 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.73469313 |
| 84 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.70335881 |
| 85 | heme transport (GO:0015886) | 3.69993634 |
| 86 | arginine metabolic process (GO:0006525) | 3.69116655 |
| 87 | glutamate metabolic process (GO:0006536) | 3.68037393 |
| 88 | hormone catabolic process (GO:0042447) | 3.67254711 |
| 89 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.65658612 |
| 90 | negative regulation of lipid transport (GO:0032369) | 3.63255245 |
| 91 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.62384356 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 3.61273530 |
| 93 | daunorubicin metabolic process (GO:0044597) | 3.59387565 |
| 94 | polyketide metabolic process (GO:0030638) | 3.59387565 |
| 95 | doxorubicin metabolic process (GO:0044598) | 3.59387565 |
| 96 | negative regulation of complement activation (GO:0045916) | 3.58968625 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.53922960 |
| 98 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.52000880 |
| 99 | acute inflammatory response (GO:0002526) | 3.49284146 |
| 100 | lipoprotein metabolic process (GO:0042157) | 3.41878720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.12604619 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.47493198 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.00798333 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.60643525 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.83467318 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.81946199 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.59923884 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.22086721 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.92600155 |
| 10 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.61936985 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.48209914 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.44142028 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10792045 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05958602 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4192094 |
| 16 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.59586647 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53415216 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37330751 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30318635 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25008022 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24404649 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23939680 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18221059 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16834437 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16026565 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04512994 |
| 27 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04145420 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.03826421 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00669616 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00125765 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99244359 |
| 32 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98512657 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98095765 |
| 34 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94628854 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93207475 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92771331 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90504592 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90504402 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85909574 |
| 40 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85625972 |
| 41 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.83936874 |
| 42 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82805670 |
| 43 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81463317 |
| 44 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81241314 |
| 45 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79675318 |
| 46 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79093194 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78353734 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76125693 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75511738 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.75500576 |
| 51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74934987 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.73754588 |
| 53 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.73502182 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71312031 |
| 55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70887957 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.69795521 |
| 57 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.68869597 |
| 58 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68815124 |
| 59 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67013307 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.66912679 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66828958 |
| 62 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.65412708 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65254034 |
| 64 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.63499098 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.61526319 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.60511370 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.60310274 |
| 68 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.60115350 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.59848139 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.59729232 |
| 71 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.59487289 |
| 72 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.59155798 |
| 73 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59004716 |
| 74 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.58788765 |
| 75 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.58306185 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57904738 |
| 77 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.57735756 |
| 78 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57689419 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.55134591 |
| 80 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.54995906 |
| 81 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.54817386 |
| 82 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54421189 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 0.53539723 |
| 84 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53036541 |
| 85 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.52793197 |
| 86 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.52096520 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.52087380 |
| 88 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.52061089 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51967870 |
| 90 | SA1_27219007_Chip-Seq_Bcells_Human | 0.51329245 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51283590 |
| 92 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.51144948 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.50914403 |
| 94 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.50742220 |
| 95 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49481131 |
| 96 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.49261423 |
| 97 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.49147554 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.48961941 |
| 99 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.47488282 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.46532606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.40651440 |
| 2 | MP0005360_urolithiasis | 6.49174512 |
| 3 | MP0005365_abnormal_bile_salt | 5.91603339 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.85158172 |
| 5 | MP0003195_calcinosis | 5.56467458 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.66063271 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.22875398 |
| 8 | MP0003252_abnormal_bile_duct | 3.55404888 |
| 9 | MP0009840_abnormal_foam_cell | 3.43732578 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.43505572 |
| 11 | MP0003868_abnormal_feces_composition | 3.43012929 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.17143667 |
| 13 | MP0009697_abnormal_copulation | 2.58724837 |
| 14 | MP0005332_abnormal_amino_acid | 2.29552702 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.17566687 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.07120505 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.02099707 |
| 18 | MP0000609_abnormal_liver_physiology | 1.90592090 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.76066550 |
| 20 | MP0001764_abnormal_homeostasis | 1.68337913 |
| 21 | MP0005408_hypopigmentation | 1.50384768 |
| 22 | MP0005451_abnormal_body_composition | 1.44518875 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.42159436 |
| 24 | MP0000604_amyloidosis | 1.37982091 |
| 25 | MP0010368_abnormal_lymphatic_system | 1.32638680 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.31206519 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.20597632 |
| 28 | MP0001915_intracranial_hemorrhage | 1.11730731 |
| 29 | MP0001661_extended_life_span | 1.10924901 |
| 30 | MP0000598_abnormal_liver_morphology | 1.07322045 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99451352 |
| 32 | MP0009643_abnormal_urine_homeostasis | 0.97682117 |
| 33 | MP0002132_abnormal_respiratory_system | 0.95248554 |
| 34 | MP0005464_abnormal_platelet_physiology | 0.94699064 |
| 35 | MP0003690_abnormal_glial_cell | 0.92782760 |
| 36 | MP0008469_abnormal_protein_level | 0.91946876 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 0.90968379 |
| 38 | MP0009642_abnormal_blood_homeostasis | 0.87791394 |
| 39 | MP0002971_abnormal_brown_adipose | 0.84185463 |
| 40 | MP0003186_abnormal_redox_activity | 0.83136621 |
| 41 | MP0005376_homeostasis/metabolism_phenot | 0.82871887 |
| 42 | MP0009053_abnormal_anal_canal | 0.82610046 |
| 43 | MP0003879_abnormal_hair_cell | 0.78455664 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 0.77644240 |
| 45 | MP0009763_increased_sensitivity_to | 0.76162863 |
| 46 | MP0003011_delayed_dark_adaptation | 0.70388580 |
| 47 | MP0003172_abnormal_lysosome_physiology | 0.69833537 |
| 48 | MP0004883_abnormal_blood_vessel | 0.67724183 |
| 49 | MP0005395_other_phenotype | 0.66937206 |
| 50 | MP0005164_abnormal_response_to | 0.64987698 |
| 51 | MP0003638_abnormal_response/metabolism_ | 0.63737406 |
| 52 | MP0009764_decreased_sensitivity_to | 0.63026555 |
| 53 | MP0002168_other_aberrant_phenotype | 0.62445230 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 0.59934505 |
| 55 | MP0003329_amyloid_beta_deposits | 0.58918708 |
| 56 | MP0005670_abnormal_white_adipose | 0.58762374 |
| 57 | MP0003075_altered_response_to | 0.58115436 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.57068672 |
| 59 | MP0000566_synostosis | 0.57067532 |
| 60 | MP0005187_abnormal_penis_morphology | 0.55805869 |
| 61 | MP0009785_altered_susceptibility_to | 0.52821446 |
| 62 | MP0000249_abnormal_blood_vessel | 0.52687619 |
| 63 | MP0003122_maternal_imprinting | 0.52474463 |
| 64 | MP0005334_abnormal_fat_pad | 0.51048964 |
| 65 | MP0005023_abnormal_wound_healing | 0.50338585 |
| 66 | MP0002282_abnormal_trachea_morphology | 0.45089273 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.44875294 |
| 68 | MP0000920_abnormal_myelination | 0.44688044 |
| 69 | MP0005535_abnormal_body_temperature | 0.42399686 |
| 70 | MP0008874_decreased_physiological_sensi | 0.42035522 |
| 71 | MP0003436_decreased_susceptibility_to | 0.41865349 |
| 72 | MP0009115_abnormal_fat_cell | 0.39941612 |
| 73 | MP0005448_abnormal_energy_balance | 0.39289937 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 0.39036937 |
| 75 | MP0003632_abnormal_nervous_system | 0.34359791 |
| 76 | MP0005166_decreased_susceptibility_to | 0.33603688 |
| 77 | MP0000639_abnormal_adrenal_gland | 0.32171018 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.32115454 |
| 79 | MP0005266_abnormal_metabolism | 0.31337931 |
| 80 | MP0003953_abnormal_hormone_level | 0.31207402 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.31203527 |
| 82 | MP0002090_abnormal_vision | 0.30412351 |
| 83 | MP0001845_abnormal_inflammatory_respons | 0.29768210 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.29727812 |
| 85 | MP0006036_abnormal_mitochondrial_physio | 0.29135071 |
| 86 | MP0001756_abnormal_urination | 0.28899486 |
| 87 | MP0005647_abnormal_sex_gland | 0.28736809 |
| 88 | MP0002419_abnormal_innate_immunity | 0.28263282 |
| 89 | MP0002970_abnormal_white_adipose | 0.26682144 |
| 90 | MP0004272_abnormal_basement_membrane | 0.25464695 |
| 91 | MP0005409_darkened_coat_color | 0.23609026 |
| 92 | MP0003633_abnormal_nervous_system | 0.23480023 |
| 93 | MP0005257_abnormal_intraocular_pressure | 0.23215151 |
| 94 | MP0003959_abnormal_lean_body | 0.23098499 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.23062897 |
| 96 | MP0005197_abnormal_uvea_morphology | 0.22985048 |
| 97 | MP0000858_altered_metastatic_potential | 0.22790257 |
| 98 | MP0001851_eye_inflammation | 0.22654199 |
| 99 | MP0005083_abnormal_biliary_tract | 0.22629751 |
| 100 | MP0005025_abnormal_response_to | 0.22027569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.38867387 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.95565798 |
| 3 | Complement deficiency (HP:0004431) | 8.39012223 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.98229601 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.48945589 |
| 6 | Joint hemorrhage (HP:0005261) | 6.70063421 |
| 7 | Abnormality of complement system (HP:0005339) | 6.69971807 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.49855425 |
| 9 | Glomerulonephritis (HP:0000099) | 5.67897573 |
| 10 | Xanthomatosis (HP:0000991) | 5.56321455 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 5.09581902 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.04148363 |
| 13 | Conjugated hyperbilirubinemia (HP:0002908) | 4.96921026 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.76346393 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 4.61803283 |
| 16 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.54284989 |
| 17 | Spontaneous abortion (HP:0005268) | 4.16746136 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.91654355 |
| 19 | Nephritis (HP:0000123) | 3.78162267 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66954892 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.56001694 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.48091330 |
| 23 | Fat malabsorption (HP:0002630) | 3.41916401 |
| 24 | Hemorrhage of the eye (HP:0011885) | 3.36571279 |
| 25 | Hypercholesterolemia (HP:0003124) | 3.35401512 |
| 26 | Gingival bleeding (HP:0000225) | 3.26321061 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.22708615 |
| 28 | Menorrhagia (HP:0000132) | 3.19223566 |
| 29 | Vascular calcification (HP:0004934) | 3.13250473 |
| 30 | Purpura (HP:0000979) | 3.13064659 |
| 31 | Mitral stenosis (HP:0001718) | 3.11433013 |
| 32 | Hyperglycinemia (HP:0002154) | 3.01377876 |
| 33 | Generalized aminoaciduria (HP:0002909) | 3.01170603 |
| 34 | Rickets (HP:0002748) | 2.97516637 |
| 35 | Hyperammonemia (HP:0001987) | 2.95758375 |
| 36 | Steatorrhea (HP:0002570) | 2.80434271 |
| 37 | Cardiovascular calcification (HP:0011915) | 2.75321547 |
| 38 | Epidermoid cyst (HP:0200040) | 2.69901265 |
| 39 | Delayed CNS myelination (HP:0002188) | 2.67909200 |
| 40 | Osteomalacia (HP:0002749) | 2.64769269 |
| 41 | Abnormality of methionine metabolism (HP:0010901) | 2.62149169 |
| 42 | Thrombophlebitis (HP:0004418) | 2.62023501 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.57253625 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.57253625 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.51287018 |
| 46 | Pulmonary embolism (HP:0002204) | 2.45701059 |
| 47 | Abnormal gallbladder physiology (HP:0012438) | 2.44122698 |
| 48 | Cholecystitis (HP:0001082) | 2.44122698 |
| 49 | Myocardial infarction (HP:0001658) | 2.38895261 |
| 50 | Hyperglycinuria (HP:0003108) | 2.37115278 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.35143787 |
| 52 | Abnormality of the Achilles tendon (HP:0005109) | 2.33624076 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.31497571 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.26112084 |
| 55 | Arthropathy (HP:0003040) | 2.21671409 |
| 56 | Hypophosphatemic rickets (HP:0004912) | 2.10044295 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.08264745 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.04572869 |
| 59 | Deep venous thrombosis (HP:0002625) | 11.1687849 |
| 60 | Bifid scrotum (HP:0000048) | 1.93112267 |
| 61 | Fair hair (HP:0002286) | 1.92808519 |
| 62 | Increased serum ferritin (HP:0003281) | 1.92672800 |
| 63 | Hydroxyprolinuria (HP:0003080) | 1.91649446 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 1.91649446 |
| 65 | Hyperphosphaturia (HP:0003109) | 1.90131533 |
| 66 | Gangrene (HP:0100758) | 1.89595162 |
| 67 | Epistaxis (HP:0000421) | 1.86509570 |
| 68 | Abnormality of vitamin metabolism (HP:0100508) | 1.85074699 |
| 69 | Metabolic acidosis (HP:0001942) | 1.84795198 |
| 70 | Irritability (HP:0000737) | 1.84593195 |
| 71 | Retinal atrophy (HP:0001105) | 1.84182554 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 1.82997817 |
| 73 | Abnormality of urine glucose concentration (HP:0011016) | 1.81898249 |
| 74 | Glycosuria (HP:0003076) | 1.81898249 |
| 75 | Elevated alkaline phosphatase (HP:0003155) | 1.81863411 |
| 76 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.80403056 |
| 77 | Joint swelling (HP:0001386) | 1.79558885 |
| 78 | Amyloidosis (HP:0011034) | 1.79463361 |
| 79 | Cholelithiasis (HP:0001081) | 1.78599652 |
| 80 | Skin nodule (HP:0200036) | 1.71510145 |
| 81 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.71251187 |
| 82 | Acanthocytosis (HP:0001927) | 1.70873182 |
| 83 | Poikilocytosis (HP:0004447) | 1.69059529 |
| 84 | Abnormal gallbladder morphology (HP:0012437) | 1.68379737 |
| 85 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67385480 |
| 86 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.67004543 |
| 87 | Enlarged kidneys (HP:0000105) | 1.62444793 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.59907558 |
| 89 | Mucopolysacchariduria (HP:0008155) | 1.59907558 |
| 90 | Hypochromic microcytic anemia (HP:0004840) | 1.59761270 |
| 91 | Abnormality of purine metabolism (HP:0004352) | 1.58246281 |
| 92 | Abnormal urine phosphate concentration (HP:0012599) | 1.57434031 |
| 93 | Abnormal tarsal ossification (HP:0008369) | 1.56854811 |
| 94 | Hypophosphatemia (HP:0002148) | 1.56653505 |
| 95 | Sensorimotor neuropathy (HP:0007141) | 1.52972738 |
| 96 | Polycythemia (HP:0001901) | 1.51981992 |
| 97 | Abnormal platelet function (HP:0011869) | 1.51694981 |
| 98 | Impaired platelet aggregation (HP:0003540) | 1.51694981 |
| 99 | Ketosis (HP:0001946) | 1.51051424 |
| 100 | Potter facies (HP:0002009) | 1.49348975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 5.94131226 |
| 2 | ERN1 | 5.48661569 |
| 3 | RIPK1 | 3.36846308 |
| 4 | FGFR3 | 3.08206601 |
| 5 | TRIB3 | 2.84793440 |
| 6 | PIK3CG | 2.62602649 |
| 7 | ICK | 2.36099780 |
| 8 | TYK2 | 2.31430078 |
| 9 | PIK3CA | 2.27965661 |
| 10 | IRAK3 | 2.11846472 |
| 11 | SIK1 | 2.00405197 |
| 12 | MAP3K3 | 1.86896308 |
| 13 | BCKDK | 1.83555552 |
| 14 | MAPK11 | 1.76340194 |
| 15 | PRKACG | 1.76327213 |
| 16 | PRKAA2 | 1.68512044 |
| 17 | TBK1 | 1.67537275 |
| 18 | TGFBR2 | 1.59939439 |
| 19 | PDPK1 | 1.57541078 |
| 20 | NEK9 | 1.55155674 |
| 21 | NTRK3 | 1.39129921 |
| 22 | MAP3K2 | 1.34484428 |
| 23 | CSF1R | 1.34228658 |
| 24 | PRKCG | 1.29024162 |
| 25 | PDK2 | 1.27520282 |
| 26 | PKN2 | 1.26747634 |
| 27 | ABL2 | 1.23499634 |
| 28 | PRPF4B | 1.21688620 |
| 29 | PDGFRA | 1.19188258 |
| 30 | CAMK1D | 1.18989300 |
| 31 | FGFR2 | 1.15964364 |
| 32 | CDK12 | 1.15902359 |
| 33 | PDK1 | 1.12440157 |
| 34 | DYRK1B | 1.11009752 |
| 35 | BLK | 1.09662941 |
| 36 | CDK6 | 1.03558557 |
| 37 | ERBB2 | 1.01107828 |
| 38 | IGF1R | 0.99094525 |
| 39 | RET | 0.96411836 |
| 40 | MAP2K4 | 0.95243656 |
| 41 | MAP3K11 | 0.93492257 |
| 42 | WNK4 | 0.87630629 |
| 43 | JAK1 | 0.87565950 |
| 44 | ZAP70 | 0.87329889 |
| 45 | FGFR1 | 0.83094431 |
| 46 | MST1R | 0.82236514 |
| 47 | MAPKAPK3 | 0.81550136 |
| 48 | MAP3K1 | 0.81159298 |
| 49 | TAOK3 | 0.80420190 |
| 50 | PRKCZ | 0.79421626 |
| 51 | EPHA3 | 0.76581269 |
| 52 | MAP2K3 | 0.76271718 |
| 53 | PRKG1 | 0.73132955 |
| 54 | MAP3K12 | 0.72443373 |
| 55 | PRKAA1 | 0.71401354 |
| 56 | CAMKK2 | 0.70950849 |
| 57 | CSNK1D | 0.70548464 |
| 58 | JAK2 | 0.70340160 |
| 59 | EIF2AK1 | 0.70303280 |
| 60 | EPHA4 | 0.69671551 |
| 61 | SGK1 | 0.69423917 |
| 62 | CAMK1G | 0.60707846 |
| 63 | SGK494 | 0.59835710 |
| 64 | SGK223 | 0.59835710 |
| 65 | TAOK2 | 0.58969448 |
| 66 | KSR2 | 0.57377908 |
| 67 | PRKACA | 0.57347692 |
| 68 | PTK6 | 0.52722128 |
| 69 | SGK3 | 0.52058490 |
| 70 | MAP3K5 | 0.51590916 |
| 71 | CDK4 | 0.50926088 |
| 72 | CSNK1E | 0.50316536 |
| 73 | SRC | 0.49928932 |
| 74 | PRKCB | 0.49211010 |
| 75 | GSK3A | 0.48994021 |
| 76 | RPS6KA3 | 0.47956318 |
| 77 | SCYL2 | 0.46829972 |
| 78 | CDC42BPA | 0.45790321 |
| 79 | CSNK2A1 | 0.43843268 |
| 80 | AKT3 | 0.43052809 |
| 81 | CAMKK1 | 0.41557164 |
| 82 | MAP3K14 | 0.40970415 |
| 83 | TNK2 | 0.40838235 |
| 84 | ERBB4 | 0.40832139 |
| 85 | MTOR | 0.40154624 |
| 86 | PRKCA | 0.39841263 |
| 87 | CSNK2A2 | 0.39528080 |
| 88 | PIM2 | 0.39423138 |
| 89 | PRKACB | 0.38028873 |
| 90 | SIK2 | 0.37878865 |
| 91 | RPS6KB1 | 0.37857390 |
| 92 | MUSK | 0.37307543 |
| 93 | TYRO3 | 0.36587186 |
| 94 | SGK2 | 0.36167368 |
| 95 | MAPK12 | 0.33152672 |
| 96 | MAPK3 | 0.31523597 |
| 97 | MAP3K6 | 0.29985545 |
| 98 | NLK | 0.29481585 |
| 99 | LATS1 | 0.28679827 |
| 100 | MET | 0.28637376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.38956199 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.12008473 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.99894173 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.57460409 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50579652 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.17663130 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.15688534 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.85464453 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.79327113 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.76065043 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.73267438 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.61796136 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.60354622 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.56317844 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.35313614 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33941479 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.17306199 |
| 18 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.01059831 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92219586 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91357336 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.85963285 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.80745604 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.66819644 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.63818667 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62590753 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61592664 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58211289 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40714872 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40366580 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.39947651 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33881912 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.32353128 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19618646 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19103068 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14651596 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14365801 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14006840 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.11924292 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11520271 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08104839 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05864796 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.05291153 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.00052281 |
| 44 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99360830 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95609328 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93563005 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90277568 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90242177 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89569031 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79345679 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78916012 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76762846 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.74034807 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69607579 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69127097 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67418175 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59419888 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59059270 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56259669 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.52844481 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.47110061 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46682822 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46545470 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42257291 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41032970 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39988017 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34959652 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27217473 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.24397461 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24369087 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23439280 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22802457 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21073577 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17067719 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17001813 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16411447 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12662283 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12543401 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.07013986 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.06860832 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.05883534 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.02625370 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2076496 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1854802 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1792525 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1741560 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1531219 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1468977 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1402573 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1238519 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0636251 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0586451 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0530980 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | -0.0474155 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0431773 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0398529 |
| 97 | Lysosome_Homo sapiens_hsa04142 | -0.0386800 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0335074 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0193407 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0153607 |

